Cancer Screening Among Patients With Advanced CancerSIMA, Camelia S; PANAGEAS, Katherine S; SCHRAG, Deborah et al.JAMA, the journal of the American Medical Association. 2010, Vol 304, Num 14, pp 1584-1591, issn 0098-7484, 8 p.Article

Estimating the Effect of a Time-Dependent Treatment by Levels of an Internal Time-Dependent Covariate: Application to the Contrast Between Liver Wait-List and Posttransplant MortalitySCHAUBEL, Douglas E; WOLFE, Robert A; SIMA, Camelia S et al.Journal of the American Statistical Association. 2009, Vol 104, Num 485, pp 49-59, issn 0162-1459, 11 p.Article

Disease Flare after Tyrosine Kinase Inhibitor Discontinuation in Patients with EGFR-Mutant Lung Cancer and Acquired Resistance to Erlotinib or Gefitinib: Implications for Clinical Trial DesignCHAFT, Jamie E; OXNARD, Geoffrey R; SIMA, Camelia S et al.Clinical cancer research (Print). 2011, Vol 17, Num 19, pp 6298-6303, issn 1078-0432, 6 p.Article

Impact of Micropapillary Histologic Subtype in Selecting Limited Resection vs Lobectomy for Lung Adenocarcinoma of 2 cm or SmallerNITADORI, Jun-Ichi; BOGRAD, Adam J; KADOTA, Kyuichi et al.Journal of the National Cancer Institute. 2013, Vol 105, Num 16, pp 1212-1220, issn 0027-8874, 9 p.Article

Tissue and Serum Mesothelin Are Potential Markers of Neoplastic Progression in Barrett's Associated Esophageal AdenocarcinomaRIZK, Nabil P; SERVAIS, Elliot L; TANG, Laura H et al.Cancer epidemiology, biomarkers & prevention. 2012, Vol 21, Num 3, pp 482-486, issn 1055-9965, 5 p.Article

Neoadjuvant and Adjuvant Chemotherapy in Resected Pulmonary Large Cell Neuroendocrine Carcinomas: A Single Institution ExperienceSARKARIA, Inderpal S; IYODA, Akira; MEE SOO ROH et al.The Annals of thoracic surgery. 2011, Vol 92, Num 4, pp 1180-1186, issn 0003-4975, 7 p.Article

Phase II study of docetaxel and vinorelbine as adjuvant chemotherapy for resected non-small cell lung cancersCHAFT, Jamie E; REKHTMAN, Natasha; SIMA, Camelia S et al.Cancer chemotherapy and pharmacology. 2013, Vol 72, Num 4, pp 931-934, issn 0344-5704, 4 p.Article

Vinorelbine and gemcitabine as second- or third-line therapy for malignant pleural mesotheliomaZAUDERER, Marjorie G; KASS, Samantha L; WOO, Kaitlin et al.Lung cancer. 2014, Vol 84, Num 3, pp 271-274, issn 0169-5002, 4 p.Article

Predicting Pulmonary Adenocarcinoma Outcome Based on a Cytology Grading SystemSIGEL, Carlie S; RUDOMINA, Dorota E; SIMA, Camelia S et al.Cancer cytopathology. 2012, Vol 120, Num 1, pp 35-43, issn 1934-662X, 9 p.Article

Management and Outcomes of Postpancreatectomy Fistula, Leak, and Abscess : Results of 908 Patients Resected at a Single Institution Between 2000 and 2005VIN, Yael; SIMA, Camelia S; GETRAJDMAN, George I et al.Journal of the American College of Surgeons. 2008, Vol 207, Num 4, pp 490-498, issn 1072-7515, 9 p.Article

Chronic inflammation in tumor stroma is an independent predictor of prolonged survival in epithelioid malignant pleural mesothelioma patientsSUZUKI, Kei; KADOTA, Kyuichi; SIMA, Camelia S et al.Cancer immunology and immunotherapy. 2011, Vol 60, Num 12, pp 1721-1728, issn 0340-7004, 8 p.Article

Long-Term Central Venous Catheter Use and Risk of Infection in Older Adults With CancerLIPITZ-SNYDERMAN, Allison; SEPKOWITZ, Kent A; ELKIN, Elena B et al.Journal of clinical oncology. 2014, Vol 32, Num 22, pp 2351-2356, issn 0732-183X, 6 p.Article

Trial of a 5-day dosing regimen of temozolomide in patients with relapsed small cell lung cancers with assessment of methylguanine-DNA methyltransferaseZAUDERER, Marjorie G; DRILON, Alex; HOLODNY, Andrei I et al.Lung cancer. 2014, Vol 86, Num 2, pp 237-240, issn 0169-5002, 4 p.Article

Thyroid Transcription Factor-1 Expression Is an Independent Predictor of Recurrence and Correlates With the IASLC/ATS/ ERS Histologic Classification in Patients With Stage I Lung AdenocarcinomaKADOTA, Kyuichi; NITADORI, Jun-Ichi; SARKARIA, Inderpal S et al.Cancer. 2013, Vol 119, Num 5, pp 931-938, issn 0008-543X, 8 p.Article

Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Lung Cancer: Distinct Natural History of Patients with Tumors Harboring the T790M MutationOXNARD, Geoffrey R; ARCILA, Maria E; SIMA, Camelia S et al.Clinical cancer research (Print). 2011, Vol 17, Num 6, pp 1616-1622, issn 1078-0432, 7 p.Article

TISSUE MICROARRAY EVIDENCE OF ASSOCIATION BETWEEN p16 AND PHOSPHORYLATED elF4E IN TONSILLAR SQUAMOUS CELL CARCINOMAFURY, Matthew G; DROBNJAK, Marija; SIMA, Camelia S et al.Head & neck. 2011, Vol 33, Num 9, pp 1340-1345, issn 1043-3074, 6 p.Article

A phase II study of pralatrexate with vitamin B12 and folic acid supplementation for previously treated recurrent and/or metastatic head and neck squamous cell cancerHO, Alan L; LIPSON, Brynna L; SALES, Roberta et al.Investigational new drugs. 2014, Vol 32, Num 3, pp 549-554, issn 0167-6997, 6 p.Article

Association of KRAS and EGFR Mutations With Survival in Patients With Advanced Lung AdenocarcinomasJOHNSON, Melissa L; SIMA, Camelia S; CHAFT, Jamie et al.Cancer. 2013, Vol 119, Num 2, pp 356-362, issn 0008-543X, 7 p.Article

Incidence of EGFR Exon 19 Deletions and L858R in Tumor Specimens From Men and Cigarette Smokers With Lung AdenocarcinomasD'ANGELO, Sandra P; CATHERINE PIETANZA, M; JOHNSON, Melissa L et al.Journal of clinical oncology. 2011, Vol 29, Num 15, pp 2066-2070, issn 0732-183X, 5 p.Article

Variability of Lung Tumor Measurements on Repeat Computed Tomography Scans Taken Within 15 MinutesOXNARD, Geoffrey R; BINSHENG ZHAO; SIMA, Camelia S et al.Journal of clinical oncology. 2011, Vol 29, Num 23, pp 3114-3119, issn 0732-183X, 6 p.Article

Mesothelin Overexpression Is a Marker of Tumor Aggressiveness and Is Associated with Reduced Recurrence-Free and Overall Survival in Early-Stage Lung AdenocarcinomaKACHALA, Stefan S; BOGRAD, Adam J; TRAVIS, William D et al.Clinical cancer research (Print). 2014, Vol 20, Num 4, pp 1020-1028, issn 1078-0432, 9 p.Article

Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung CancersYU, Helena A; ARCILA, Maria E; REKHTMAN, Natasha et al.Clinical cancer research (Print). 2013, Vol 19, Num 8, pp 2240-2247, issn 1078-0432, 8 p.Article

Driver Mutations Determine Survival in Smokers and Never-Smokers With Stage IIIB/IV Lung AdenocarcinomasPAIK, Paul K; JOHNSON, Melissa L; D'ANGELO, Sandra P et al.Cancer. 2012, Vol 118, Num 23, pp 5840-5847, issn 0008-543X, 8 p.Article

Maintained Sensitivity to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Lung Cancer Recurring after Adjuvant Erlotinib or GefitinibOXNARD, Geoffrey R; JANJIGIAN, Yelena Y; MILLER, Vincent A et al.Clinical cancer research (Print). 2011, Vol 17, Num 19, pp 6322-6328, issn 1078-0432, 7 p.Article

Clinical Impact of Immune Microenvironment in Stage I Lung Adenocarcinoma: Tumor Interleukin-12 Receptor β2 (IL-12Rβ2), IL-7R, and Stromal FoxP3/CD3 Ratio Are Independent Predictors of RecurrenceSUZUKI, Kei; KADOTA, Kyuichi; SIMA, Camelia S et al.Journal of clinical oncology. 2013, Vol 31, Num 4, pp 490-498, issn 0732-183X, 9 p.Article